Supplemental Consolidated Financial Information (Tables)

3 Months Ended

Mar. 31, 2023

Balance Sheet Components [Abstract]

Schedule of cash and cash equivalents

Cash, cash equivalents and restricted cash

	March 31, 2023		December 31, 2022
	(In millions)
Cash and cash equivalents	$	2,082	$	2,154
Customer accounts	303		69
Restricted cash included in short-term investments	41		36
Restricted cash included in long-term investments	5		13
Cash, cash equivalents and restricted cash	$	2,431	$	2,272

Restrictions on cash and cash equivalents

Cash, cash equivalents and restricted cash

	March 31, 2023		December 31, 2022
	(In millions)
Cash and cash equivalents	$	2,082	$	2,154
Customer accounts	303		69
Restricted cash included in short-term investments	41		36
Restricted cash included in long-term investments	5		13
Cash, cash equivalents and restricted cash	$	2,431	$	2,272

Customer accounts and funds receivable

Customer accounts and funds receivable

	March 31, 2023		December 31, 2022
	(In millions)
Customer accounts	$	303	$	69
Funds receivable	476		694
Customer accounts and funds receivable	$	779	$	763

Schedule of other current assets

Other current assets

	March 31, 2023		December 31, 2022
	(In millions)
Payment processor advances	$	353	$	336
Prepaid expenses	115		120
Accounts receivable, net	80		90
Short-term derivative assets	57		112
Income and other tax receivable	44		122
Other	300		276
Other current assets	$	949	$	1,056

Schedule of accrued expenses and other current liabilities

Accrued expenses and other current liabilities

	March 31, 2023		December 31, 2022
	(In millions)
Compensation and related benefits	$	393	$	426
Sales and use tax and VAT accruals	386		346
Advertising accruals	214		229
Operating lease liabilities	125		131
Transaction loss reserve	101		101
Uninvoiced general and administrative expenses	95		111
Accrued interest expense	74		67
Deferred revenue	45		34
Other	396		421
Accrued expenses and other current liabilities	$	1,829	$	1,866

Schedule of gain (loss) on equity method investments and warrants

Gain (loss) on equity investments and warrant, net

	Three Months Ended March 31,
	2023		2022
	(In millions)
Unrealized change in fair value of equity investment in Adevinta	$	174	$	(1,643)
Unrealized change in fair value of equity investment in Adyen	—		(80)
Unrealized change in fair value of equity investment in Gmarket	(11)		(182)
Unrealized change in fair value of equity investment in KakaoBank	(3)		(91)
Change in fair value of warrant	38		(115)
Realized change in fair value of shares sold in Adyen	—		(166)
Realized change in fair value of shares sold in KakaoBank	—		(8)
Gain (loss) on other investments	—		(6)
Total gain (loss) on equity investments and warrant, net	$	198	$	(2,291)